V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009264 | 280009397 | 1.74 | 85.1 | Curative (C) | 2018-06-14 | 2018-07-05 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280030524 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009265 | 280009397 | 1.57 | 85.8 | Curative (C) | 2013-10-20 | 2014-10-03 | Rituximab | 02 | N | 280030524 | VINCRISTINE |
| 280009266 | 280006524 | 0 | null | Not known (9) | 2017-04-03 | 2017-04-03 | LANREOTIDE | 02 | N | 280030530 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009267 | 280011460 | 1.76 | 87 | Curative (C) | 2017-07-02 | 2017-07-25 | VIDE | 02 | N | 280030533 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009268 | 280006525 | null | 40.5 | Curative (C) | 2014-12-23 | 2014-12-26 | Etoposide IV | 99 | N | 280030534 | DOCETAXEL |
| 280009269 | 280006525 | 1.75 | 52 | Neo-adjuvant (N) | null | 2018-06-20 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 280030534 | BUSULFAN + MELPHALAN |
| 280009270 | 280006525 | 1.75 | 114 | Palliative (P) | 2014-06-13 | 2015-06-05 | VIDE | 02 | N | 280030534 | LIPOSOMAL DOXORUBICIN |
| 280009271 | 280006527 | null | null | Palliative (P) | 2017-06-08 | 2018-01-10 | TIMELY TRIAL | null | null | 280030545 | BENDAMUSTINE + RITUXIMAB |
| 280009272 | 280006528 | 0 | 75.6 | Palliative (P) | 2014-07-22 | 2014-07-30 | TEMOZOLOMIDE | N | N | 280030546 | CARBOPLATIN + CETUXIMAB + FU |
| 280009273 | 280006529 | 1.71 | 55 | Adjuvant (A) | 2013-12-08 | 2013-12-18 | Cisplatin + Fluorouracil + RT 5day | null | null | 280030548 | METHOTREXATE HIGH DOSE |
| 280009275 | 280010783 | 1.53 | null | Palliative (P) | 2015-01-27 | 2015-04-17 | IVADo | N | N | 280030560 | METHOTREXATE |
| 280009276 | 280006530 | 1.61 | 75 | Palliative (P) | 2013-03-21 | 2013-04-28 | Dactinomycin + Vincristine | N | N | 280030568 | PAZOPANIB |
| 280009277 | 280006530 | 1.65 | null | Palliative (P) | null | 2016-09-04 | Cisplatin + Topotecan | N | N | 280030568 | CVD |
| 280009278 | 280006530 | 1.65 | 61.6 | Palliative (P) | 2017-03-14 | 2017-06-30 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280030568 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009279 | 280012129 | 1.88 | 66.4 | Palliative (P) | 2016-10-18 | 2016-11-27 | INTERFERON | N | N | 280030583 | CARBO + FLUOROURACIL |
| 280009280 | 280006531 | 1.7 | 71.8 | Palliative (P) | 2017-02-18 | 2017-03-25 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | 280030588 | DOCETAXEL |
| 280009281 | 280006532 | 1.74 | 72 | Palliative (P) | 2016-01-28 | 2016-01-28 | Capecitabine (14 days)+Carboplatin | N | N | 280030591 | CARBOPLATIN + CETUXIMAB + FU |
| 280009282 | 280006533 | 1.75 | 115 | Palliative (P) | 2016-09-28 | 2016-10-12 | IVADo | 2 | N | 280030593 | CARBO + FLUOROURACIL |
| 280009283 | 280006534 | 1.75 | 52.5 | Palliative (P) | 2016-05-03 | 2017-04-19 | Liposomal Doxorubicin 50mg/m2 | null | null | 280030598 | SUNITINIB |
| 280009284 | 280006534 | null | 79.7 | Palliative (P) | 2014-10-29 | 2014-11-06 | Sorafenib | N | N | 280030598 | VIA |
| 280009285 | 280006535 | 1.59 | 52 | Neo-adjuvant (N) | 2018-01-11 | 2018-07-29 | VIDE | N | N | 280030610 | IVADO |
| 280009286 | 280006536 | 1.64 | 61.9 | Curative (C) | 2015-10-07 | 2015-11-18 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280030616 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009287 | 280009406 | 1.7 | 48.5 | Neo-adjuvant (N) | 2019-03-08 | 2019-03-21 | BCG Intravesical | 02 | N | 280030627 | RITUXIMAB |
| 280009288 | 280011463 | 1.68 | 61.3 | Palliative (P) | 2016-01-07 | 2016-01-21 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 280030628 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280009289 | 280006538 | 1.55 | 82.7 | Adjuvant (A) | 2016-05-12 | 2016-06-08 | Vinorelbine (oral) | 2 | null | 280030629 | CARBO + FLUOROURACIL |
| 280009290 | 280006541 | 1.67 | 60.3 | Palliative (P) | 2014-07-16 | 2014-08-08 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280030630 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009291 | 280006541 | 1.82 | 65 | Neo-adjuvant (N) | 2015-03-04 | 2015-03-04 | NIVOLUMAB | 02 | N | 280030630 | CAPECITABINE |
| 280009292 | 280006542 | 1.64 | 107 | Palliative (P) | 2014-08-03 | 2014-08-25 | Eribulin | N | N | 280030635 | FLUOROURACIL + MITOMYCIN + RT |
| 280009293 | 280006545 | null | 89.8 | Palliative (P) | 2016-06-05 | 2016-06-07 | Capecitabine | N | N | 280030636 | CARBO + FLUOROURACIL |
| 280009294 | 280006545 | 1.85 | 68 | Palliative (P) | 2018-05-24 | 2018-05-25 | Docetaxel + Nintedanib | N | N | 280030636 | CISPLATIN + DOCETAXEL |
| 280009295 | 280006547 | 1.59 | 67.2 | Palliative (P) | 2015-10-01 | 2015-10-01 | NIVOLUMAB | N | null | 280030639 | ETOPOSIDE |
| 280009296 | 280006548 | 1.73 | 70 | null | 2017-12-06 | 2017-12-14 | MELPHALAN | N | N | 280030639 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009297 | 280011464 | 1.81 | 63 | Palliative (P) | 2018-05-09 | 2018-05-09 | Enzalutamide | 01 | N | 280030646 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009298 | 280006549 | null | null | Palliative (P) | 2018-02-12 | 2018-02-15 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 280030649 | METHOTREXATE INTRATHECAL |
| 280009299 | 280006549 | 1.6 | 85.8 | Curative (C) | 2016-12-28 | 2017-01-05 | IVADo | N | N | 280030649 | FCR |
| 280009300 | 280006550 | 1.73 | null | Palliative (P) | 2015-12-11 | 2015-12-12 | PERTUZUMAB + TRASTUZUMAB | N | N | 280030660 | ETOPOSIDE |
| 280009301 | 280009412 | 1.65 | 87.8 | Palliative (P) | 2016-06-22 | 2016-06-22 | Irinotecan | N | null | 280030663 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280009302 | 280009412 | 1.87 | 108 | null | 2016-11-16 | 2016-12-03 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 280030663 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009303 | 280006553 | 1.8 | 94 | null | 2016-04-15 | 2016-04-15 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280030668 | IMATINIB |
| 280009304 | 280006553 | 1.75 | 83.7 | Palliative (P) | 2017-08-17 | 2017-09-01 | Fluouracil continuous infusion | null | null | 280030668 | DOCETAXEL |
| 280009305 | 280006554 | 1.87 | 59.3 | Adjuvant (A) | 2014-12-29 | 2014-12-29 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280030674 | CISPLATIN + FLUOROURACIL + RT |
| 280009306 | 280006554 | 1.88 | 61.1 | Neo-adjuvant (N) | 2014-10-13 | 2014-10-16 | ECX | 01 | N | 280030674 | CISPLATIN + FLUOROURACIL + RT |
| 280009307 | 280006554 | 1.74 | 92 | Palliative (P) | 2016-03-13 | 2016-03-17 | Capecitabine | 02 | null | 280030674 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280009308 | 280006554 | 1.55 | 108.6 | Palliative (P) | 2015-08-26 | 2015-11-21 | GEDDIS TRIAL | N | N | 280030674 | CARBOPLATIN + CETUXIMAB |
| 280009309 | 280006559 | 1.87 | 77.05 | Adjuvant (A) | 2016-03-05 | 2016-03-11 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 2 | N | 280030690 | CARBO + FLUOROURACIL |
| 280009310 | 280006560 | 1.83 | 74.3 | Palliative (P) | 2014-05-30 | 2014-06-23 | CMV | N | N | 280030692 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT |
| 280009311 | 280006561 | 1.8 | 67 | Disease modification (D) | 2013-11-21 | 2013-11-25 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280030695 | CVP R |
| 280009312 | 280006563 | 1.73 | 52.3 | Adjuvant (A) | 2018-07-18 | 2018-07-19 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280030699 | DOXORUBICIN + GEMCITABINE |
| 280009313 | 280006566 | 1.78 | 84.6 | Adjuvant (A) | 2018-01-27 | 2018-02-04 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280030701 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009314 | 280006567 | 1.7 | 61.1 | Curative (C) | 2018-08-19 | 2018-08-20 | BEP 5 Day | N | null | 280030702 | ETOPOSIDE |